GCP
AMGN icon

GSA Capital Partners’s Amgen AMGN Stock Holding History

GSA Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$460K Buy
+1,307
New +$466K 0.03% 971
2025
Q4 		– Sell
-923
Closed -$260K – 1645
2025
Q3 		$260K Sell
923
-1,439
-61% -$417K 0.02% 1280
2025
Q2 		$659K Buy
2,362
+1,069
+83% +$303K 0.05% 731
2025
Q1 		$403K Sell
1,293
-1,145
-47% -$338K 0.04% 946
2024
Q4 		$635K Sell
2,438
-282
-10% -$83.7K 0.05% 725
2024
Q3 		$876K Buy
+2,720
New +$890K 0.07% 554
2022
Q3 		– Sell
-4,538
Closed -$1.1M – 1482
2022
Q2 		$1.1M Buy
+4,538
New +$1.11M 0.17% 105
2021
Q4 		– Sell
-3,121
Closed -$664K – 1388
2021
Q3 		$664K Buy
+3,121
New +$718K 0.07% 522
2020
Q2 		– Sell
-1,960
Closed -$397K – 602
2020
Q1 		$397K Sell
1,960
-2,638
-57% -$576K 0.1% 290
2019
Q4 		$1.11M Sell
4,598
-206
-4% -$45.4K 0.13% 167
2019
Q3 		$930K Sell
4,804
-5,248
-52% -$1.01M 0.13% 188
2019
Q2 		$1.85M Sell
10,052
-3,209
-24% -$575K 0.21% 52
2019
Q1 		$2.52M Buy
13,261
+7,094
+115% +$1.35M 0.26% 42
2018
Q4 		$1.2M Sell
6,167
-2,216
-26% -$432K 0.14% 149
2018
Q3 		$1.74M Sell
8,383
-623
-7% -$123K 0.1% 318
2018
Q2 		$1.66M Sell
9,006
-9,128
-50% -$1.61M 0.08% 372
2018
Q1 		$3.09M Buy
18,134
+2,999
+20% +$551K 0.16% 109
2017
Q4 		$2.63M Buy
15,135
+11,478
+314% +$2.03M 0.16% 121
2017
Q3 		$682K Buy
+3,657
New +$648K 0.05% 758
2017
Q2 		– Sell
-38,156
Closed -$6.26M – 1649
2017
Q1 		$6.26M Buy
38,156
+19,635
+106% +$3.26M 0.34% 5
2016
Q4 		$2.71M Sell
18,521
-34,165
-65% -$5.14M 0.16% 116
2016
Q3 		$8.79M Buy
52,686
+33,422
+173% +$5.65M 0.47% 7
2016
Q2 		$2.93M Buy
19,264
+1,059
+6% +$165K 0.16% 109
2016
Q1 		$2.73M Sell
18,205
-6,094
-25% -$905K 0.17% 86
2015
Q4 		$3.94M Sell
24,299
-50,946
-68% -$8.01M 0.19% 64
2015
Q3 		$10.4M Buy
75,245
+43,194
+135% +$6.81M 0.51% 10
2015
Q2 		$4.92M Buy
32,051
+267
+0.8% +$42.8K 0.19% 55
2015
Q1 		$5.08M Buy
31,784
+6,950
+28% +$1.09M 0.2% 50
2014
Q4 		$3.96M Buy
24,834
+23,384
+1,613% +$3.64M 0.28% 23
2014
Q3 		$204K Buy
+1,450
New +$189K 0.01% 1514
2014
Q2 		– Sell
-3,509
Closed -$433K – 1784
2014
Q1 		$433K Sell
3,509
-4,043
-54% -$490K 0.03% 884
2013
Q4 		$862K Sell
7,552
-38,082
-83% -$4.33M 0.07% 457
2013
Q3 		$5.11M Buy
45,634
+36,699
+411% +$3.98M 0.4% 16
2013
Q2 		$882K Buy
+8,935
New +$927K 0.1% 257

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

GSA Capital Partners's AMGN Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Amgen (AMGN) in Q1 2026: 1,307 shares worth $460K. The stake represents 0.03% of the portfolio and ranks #971 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in AMGN as recently as Q3 2025.

GSA Capital Partners first reported a position in AMGN in Q2 2013 and has held it in 34 quarters since. The position peaked at $10.4M in Q3 2015. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • GSA Capital Partners held 1,307 shares of Amgen worth $460K as of Q1 2026.
  • Amgen was a new GSA Capital Partners position in Q1 2026.
  • Amgen made up 0.03% of GSA Capital Partners's portfolio in Q1 2026, its #971 holding.
  • GSA Capital Partners first reported a position in Amgen in Q2 2013 and has held it in 34 quarters since.
  • GSA Capital Partners's Amgen position peaked at $10.4M in Q3 2015.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.